<DOC>
	<DOCNO>NCT01194037</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability ascend dos Hanferon™ combination ribavirin ( RBV ) . The secondary objective study define PK PD ascend dos Hanferon™ combination RBV . The exploratory objective study make preliminary assessment Hanferon™ efficacy combination RBV .</brief_summary>
	<brief_title>A Phase 1b/2a , Open-label , Randomized , Safety , Tolerability , Dose Finding , PK/PD , Preliminary Efficacy Study SC Hanferon™ Combination With Ribavirin Treatment-naïve Subjects With Genotype 1 Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Diagnosis chronic hepatitis C genotype 1a 1b Male female age 18 65 year , inclusive Compensated liver disease without evidence cirrhosis No evidence type 1 2 diabetes mellitus , lipodystrophy polycystic ovary syndrome No history presence autoimmune lymphoproliferative disease hemoglobinopathy Stable medication dos 1 month chronic disease subject chronic disease , include limited hypertension dyslipidemia History previous treatment hepatitis C Currently use medication psychiatric illness include depression , suicidal ideation , psychosis History presence chronic liver disease History drug alcohol abuse within past year Evidence active illicit drug use Clinically significant abnormal electrocardiogram ( ECG ) rhythm strip Female subject positive urine pregnancy test lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>HCV</keyword>
	<keyword>Interferon</keyword>
	<keyword>Hanferon</keyword>
</DOC>